Testing a Digital Self-Management Program for Inflammatory Bowel Disease
Tests a digital program helping adults with ulcerative colitis or Crohn disease manage their health.
Plain-language title generated from the registry record
Registry title: Developing a Self-Management Intervention to Improve Health Outcomes for Patients With Inflammatory Bowel Disease
Key facts
- Where
- Ann Arbor, United StatesSee the site
Where in United States
- University of MiciganAnn Arbor, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of Michigan
- Trial code
- NCT07456566
- Record updated
- 23 July 2026
- Original description
This research is studying whether changing an individual's behaviors may have an impact as a treatment or outcome for inflammatory bowel disease. This research will increase the understanding of the role of a self-management program in improving health and health-related quality of life for patients with inflammatory bowel disease.Read full original descriptionShow less
Developing a Self-Management Intervention to Improve Health Outcomes for Patients With Inflammatory Bowel Disease: Part 3 Pilot Trial
This research is studying whether changing an individual's behaviors may have an impact as a treatment or outcome for inflammatory bowel disease. This research will increase the understanding of the role of a self-management program in improving health and health-related quality of life for patients with inflammatory bowel disease.
The study team hypothesizes:
* the study will achieve a recruitment rate of 10 participants every 3 months * 70% participant retention at 24 weeks * 70% outcome data collection * 70% intervention completion * high acceptability
Inclusion: Diagnosis of Inflammatory Bowel Disease (IBD) based on conventional clinical, endoscopic, and histopathological criteria, clinically active IBD; Impaired health-related quality of life; Clinically active IBD will be indicated by both a modified Harvey Bradshaw Index (HBI) ≥5 for Crohn's disease (CD) or a Simple Clinical Colitis Activity Index (SCCAI) ≥3 for ulcerative colitis (UC); Fecal calprotectin > 250 microgram (ug/g); Impaired IBD-specific health-related quality of life will be defined as a Short IBD Questionnaire score ≤ 60.
Exclusion: Are planned for imminent surgery; Have short bowel syndrome; Uncontrolled medical or psychiatric disease; Unable to speak and read English; Unable to access the internet regularly by phone or web as this will impair participants ability to engage with the intervention components; Have an ileostomy, colostomy, ileoanal pouch, or ileorectal anastomoses.